Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

David N. Krag, Stewart Anderson, Thomas B. Julian et al. · The Lancet Oncology · 2010 · 1.9K citations · Full text

Medicine, Oncology, Surgery +17

Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update

Antonio C. Wolff, M. Elizabeth Hammond, David G. Hicks et al. · Archives of Pathology & Laboratory Medicine · 2013 · 1.8K citations · Full text

Medicine, Oncology, Pathology +14

Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer

Judy C. Boughey · JAMA · 2013 · 1.6K citations · Full text

Medicine, Oncology, Surgery +17

Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study

Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm et al. · The Lancet Oncology · 2013 · 1.5K citations

Medicine, Oncology, Surgery +17

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection

Abigail S. Caudle, Wei Yang, Savitri Krishnamurthy et al. · Journal of Clinical Oncology · 2016 · 889 citations

Medicine, Pathology, Surgery +17